Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Transmitted antiretroviral drug resistance in New York State, 2006-2008: results from a new surveillance system.

Readhead AC, Gordon DE, Wang Z, Anderson BJ, Brousseau KS, Kouznetsova MA, Forgione LA, Smith LC, Torian LV.

PLoS One. 2012;7(8):e40533. doi: 10.1371/journal.pone.0040533. Epub 2012 Aug 6.

2.

Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses.

Kraft CS, Basu D, Hawkins PA, Hraber PT, Chomba E, Mulenga J, Kilembe W, Khu NH, Derdeyn CA, Allen SA, Manigart O, Hunter E.

Retrovirology. 2012 Mar 20;9:22. doi: 10.1186/1742-4690-9-22.

3.

Recombination between variants from genital tract and plasma: evolution of multidrug-resistant HIV type 1.

Kemal KS, Ramirez CM, Burger H, Foley B, Mayers D, Klimkait T, Hamy F, Anastos K, Petrovic K, Minin VN, Suchard MA, Weiser B.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1766-74. doi: 10.1089/AID.2011.0383. Epub 2012 Apr 10.

4.

Detection of HIV-1 dual infections in highly exposed treated patients.

Andreani G, Espada C, Ceballos A, Ambrosioni J, Petroni A, Pugliese D, Bouzas MB, Fernandez Giuliano S, Weissenbacher MC, Losso M, Benetucci J, Carr JK, Martínez Peralta L.

Virol J. 2011 Aug 8;8:392. doi: 10.1186/1743-422X-8-392.

5.

Differences in reversion of resistance mutations to wild-type under structured treatment interruption and related increase in replication capacity.

Paquet AC, Baxter J, Weidler J, Lie Y, Lawrence J, Kim R, Bates M, Coakley E, Chappey C.

PLoS One. 2011 Jan 31;6(1):e14638. doi: 10.1371/journal.pone.0014638.

6.

Implementation of HIV testing at 2 New York City bathhouses: from pilot to clinical service.

Daskalakis D, Silvera R, Bernstein K, Stein D, Hagerty R, Hutt R, Maillard A, Borkowsky W, Aberg J, Valentine F, Marmor M.

Clin Infect Dis. 2009 Jun 1;48(11):1609-16. doi: 10.1086/598979.

7.

Influence of social changes on the evolution of HIV infection in Romania.

Rutã S, Cernescu C.

Int J Environ Stud. 2008;65(4):501-513.

8.

Evaluation of the impact of news coverage of an HIV multiclass drug-resistant cluster in Seattle, Washington.

Kahle EM, Barash EA, Page LC, Lansky A, Jafa K, Sullivan PS, Buskin SE.

Am J Public Health. 2009 Apr;99 Suppl 1:S131-6. doi: 10.2105/AJPH.2007.126656. Epub 2009 Feb 12.

9.

Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate.

Yeh WW, Jaru-Ampornpan P, Nevidomskyte D, Asmal M, Rao SS, Buzby AP, Montefiori DC, Korber BT, Letvin NL.

J Virol. 2009 Mar;83(6):2686-96. doi: 10.1128/JVI.02237-08. Epub 2009 Jan 7. Erratum in: J Virol. 2009 May;83(10):5293.

10.

Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration.

Cachay ER, Moini N, Kosakovsky Pond SL, Pesano R, Lie YS, Aiem H, Butler DM, Letendre S, Mathews WC, Smith DM.

Open AIDS J. 2007;1:5-10. doi: 10.2174/1874613600701010005. Epub 2007 Oct 22.

11.

The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.

Stevceva L, Yoon V, Carville A, Pacheco B, Santosuosso M, Korioth-Schmitz B, Mansfield K, Poznansky MC.

J Immunol. 2008 Oct 15;181(8):5510-21.

12.

Inferring HIV transmission dynamics from phylogenetic sequence relationships.

Pilcher CD, Wong JK, Pillai SK.

PLoS Med. 2008 Mar 18;5(3):e69. doi: 10.1371/journal.pmed.0050069. No abstract available.

13.

Identifying HIV-1 dual infections.

van der Kuyl AC, Cornelissen M.

Retrovirology. 2007 Sep 24;4:67. Review.

Supplemental Content

Support Center